Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Infant Formula Nutrient Levels Addressed In U.S. Codex Draft Position

This article was originally published in The Tan Sheet

Executive Summary

Essential nutrient minimum levels in infant formulas should be based on the mean levels found in breast milk, while maximum amounts should be set "when there is evidence of adverse health effects at higher levels," according to the draft position on infant formula proposed by the U.S. delegation to the Codex Alimentarius

You may also be interested in...



Codex Health Claims Guides Development Renewed By Nutrition Committee

The Codex Alimentarius Committee on Nutrition & Foods for Special Dietary Uses (CCNFSDU) is planning to initiate "new work" on the elaboration of proposed draft recommendations on the scientific basis for health claims, according to a recently-released Codex report

Codex Health Claims Guides Development Renewed By Nutrition Committee

The Codex Alimentarius Committee on Nutrition & Foods for Special Dietary Uses (CCNFSDU) is planning to initiate "new work" on the elaboration of proposed draft recommendations on the scientific basis for health claims, according to a recently-released Codex report

Codex Health Claims Guides Development Renewed By Nutrition Committee

The Codex Alimentarius Committee on Nutrition & Foods for Special Dietary Uses (CCNFSDU) is planning to initiate "new work" on the elaboration of proposed draft recommendations on the scientific basis for health claims, according to a recently-released Codex report

Related Content

Topics

UsernamePublicRestriction

Register

PS078529

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel